Nishiyama M - Search Results

1

Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.

Kim R, Hirabayashi N, Nishiyama M, Saeki S, Toge T, Okada K. Kim R, et al. Among authors: nishiyama m. Anticancer Res. 1991 Jan-Feb;11(1):429-31. Anticancer Res. 1991. PMID: 1850221

2

Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.

Yoshida K, Hirabayashi N, Takiyama W, Ninomiya M, Takakura N, Sakamoto J, Nishiyama M, Toge T. Yoshida K, et al. Among authors: nishiyama m. Anticancer Res. 2004 May-Jun;24(3b):1843-51. Anticancer Res. 2004. PMID: 15274365 Free article. Clinical Trial.

3

Experimental studies on biochemical modulation targeting topoisomerase I and II in human tumor xenografts in nude mice.

Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T, Okada K. Kim R, et al. Among authors: nishiyama m. Int J Cancer. 1992 Mar 12;50(5):760-6. doi: 10.1002/ijc.2910500516. Int J Cancer. 1992. PMID: 1312063

4

Factors contributing to adriamycin sensitivity in human xenograft tumors: the relationship between expression of the MDR1, GST-pi and topoisomerase II genes and tumor sensitivity to adriamycin.

Kim R, Hirabayashi N, Nishiyama M, Jinushi K, Toge T, Okada K. Kim R, et al. Among authors: nishiyama m. Anticancer Res. 1992 Jan-Feb;12(1):241-5. Anticancer Res. 1992. PMID: 1314532

5

A role for plasma membrane potential in doxorubicin--induced cytotoxicity.

Nishiyama M, Aogi K, Saeki S, Kim R, Kuroi K, Yamaguchi Y, Toge T. Nishiyama M, et al. Anticancer Res. 1992 May-Jun;12(3):849-52. Anticancer Res. 1992. PMID: 1622144

6

mRNA expression of topoisomerase II in human tumors and normal tissues.

Kim R, Hirabayashi N, Nishiyama M, Yorishima T, Toge T, Okada K. Kim R, et al. Among authors: nishiyama m. Jpn J Surg. 1991 Sep;21(5):587-9. doi: 10.1007/BF02471001. Jpn J Surg. 1991. PMID: 1667537

7

Clinical significance of P-glycoprotein expression analyzed by immunohistochemical staining in cancer tissues.

Kim R, Hirabayashi N, Nishiyama M, Aogi K, Toge T. Kim R, et al. Among authors: nishiyama m. Jpn J Surg. 1991 Sep;21(5):590-3. doi: 10.1007/BF02471002. Jpn J Surg. 1991. PMID: 1687601

8

Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.

Kawami H, Yoshida K, Ohsaki A, Kuroi K, Nishiyama M, Toge T. Kawami H, et al. Among authors: nishiyama m. Anticancer Res. 1993 Nov-Dec;13(6A):2319-23. Anticancer Res. 1993. PMID: 8297152

9

A novel in vitro chemosensitivity test using materials collected by endoscopic biopsy.

Hirai T, Kawano K, Hirabayashi N, Nishiyama M, Yamashita Y, Mukaida H, Iwata T, Toge T. Hirai T, et al. Among authors: nishiyama m. Anticancer Drugs. 1991 Jun;2(3):269-74. doi: 10.1097/00001813-199106000-00008. Anticancer Drugs. 1991. PMID: 1802022

10

[Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines].

Nishiyama M, Aogi K, Saeki S, Hirabayashi N, Toge T. Nishiyama M, et al. Gan To Kagaku Ryoho. 1991 Nov;18(14):2429-33. Gan To Kagaku Ryoho. 1991. PMID: 1952962 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,217 results

Search Page

Filters